COMPANY PROFILE

Eyedeal / 眼得乐

Explore full profile

Innovative implantable medical devices leveraging advanced xPIB material for enhanced patient outcomes

Xi'an, ChinaFounded 2015Health Tech & Medtech

Valuation $50–100M Last recorded · 2023

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Eyedeal / 眼得乐

Eyedeal is a pioneering company in the field of implantable medical devices, leveraging advanced xPIB material to enhance patient outcomes. The company serves a diverse range of clients, including hospitals, medical research institutions, and healthcare providers. Operating in the highly specialized medical device market, Eyedeal's business model focuses on research, development, and commercialization of cutting-edge medical technologies. Revenue is generated through the sale of its innovative products, licensing agreements, and participation in high-profile national science and technology programs. Eyedeal has been granted significant support from governmental bodies, such as the Ministry of Science and Technology and the National Medical Products Administration, which underscores its credibility and potential for growth. The company's leadership includes distinguished experts in biomedical engineering and ophthalmology, further solidifying its position as a leader in medical innovation.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: Xi'an, China
Open positions: None listed
Dealroom signal: 19.7/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Ophthalmology, medical implants, Surgery, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Apr 2023	$14M	$55M	China Europe Shengshi · Taimeng Investment Group · Yuansheng Venture Capital	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Eyedeal / 眼得乐 website traffic

Latest recorded traffic for Eyedeal / 眼得乐 is 2.1K monthly website visits, up 138.6% over the last three months.

Latest monthly visits2.1K 3-month web change+138.6%

Monthly website visitsApr 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NONew Industry OphthalmologyA company focused on optical products such as cataract intraocular lens	Shaoyang, China	Operational	—	$19M	—
MVMyra VisionCalibreye™, a next-generation aqueous shunt therapy for patients with moderate to severe glaucoma, providing predictable outcomes and personalized flow, with successful first-in-human use and $25M	Campbell, United States	Operational
LMLIQID MedicalA clinical-stage medical technology company pioneering a new class of highly effective glaucoma devices	Cape Town, South Africa	Operational
ALAlievioDeveloper of a glaucoma therapy that can stop the progression of glaucoma	Durham, United States	Operational
MSMercy SpinePatented micro balloon device for back pain	Klamath Falls, United States	Operational
OIOPTIMOTION IMPLANTSTHE NEXT GENERATION TOTAL KNEE REPLACEMENT	Orlando, United States	Operational
TSToetal SolutionsA medical device company that develops simple, effective, and surgeon-designed foot and ankle solutions	Philadelphia, United States	Operational
DMDekang MedicalInnovative medical devices specializing in trauma and articular series for enhanced patient care	Jiaxing, China	Operational